Hemolytic Performance of a MagLev Disposable Rotary Blood Pump (MedTech Dispo): Effects of MagLev Gap Clearance and Surface Roughness

• Published in: Artificial organs 2006-12, Vol.30 (12), p.949-954
• Main Authors: Hoshi, Hideo, Asama, Junichi, Hijikata, Wataru, Hara, Chikara, Shinshi, Tadahiko, Yasuda, Toshitaka, Ohuchi, Katsuhiro, Shimokohbe, Akira, Takatani, Setsuo
• Format: Article
• Language: English
• Subjects: Animals; Biomedical Engineering; Centrifugal blood pump; Centrifugation; Equipment Design; Heart-Assist Devices; Hemolysis; MagLev gap clearance; Magnetic levitation; Magnetics; Surface Properties; Surface roughness; Swine
• ISSN: 0160-564X; 1525-1594
• DOI: 10.1111/j.1525-1594.2006.00332.x

:  Mechanical shaft seal bearing incorporated in the centrifugal blood pumps contributes to hemolysis and thrombus formation. In addition, the problem of durability and corrosion of mechanical shaft seal bearing has been recently reported from the safety point of view. To amend the shortcomings of the blood‐immersed mechanical bearings, a magnetic levitated centrifugal rotary blood pump (MedTech Dispo Model 1; Tokyo Medical and Dental University, Tokyo, Japan) has been developed for extracorporeal disposable application. In this study, the hemolytic performance of the MedTech Dispo Model 1 centrifugal blood pump system was evaluated, with special focus on the narrow blood path clearance at the magnetic bearing between rotor and stator, and on the pump housing surface roughness. A pump flow of 5 L/min against the head pressure of 100 mm Hg for 4 h was included in the hemolytic test conditions. Anticoagulated fresh porcine blood was used as a working fluid. The clearance of blood path at the magnetic bearing was in the range of 100–250 μm. Pump housing surface roughness was controlled to be around Ra = 0.1–1.5 μm. The lowest hemolytic results were obtained at the clearance of 250 μm and with the polished surface (Ra = 0.1 μm) yielding the normalized index of hemolysis (NIH) of less than 0.001 g/100 L, which was 1/5 of the Biopump BP‐80 (Medtronic Inc., Minneapolis, MN, USA, and 1/4 of the BPX‐80. In spite of rough surface and narrow blood path, NIH levels were less than clinically acceptable level of 0.005 g/100 L. The noncontact, levitated impeller system is useful to improve pump performance in blood environment.